Skip to main content
Back
Watch Compare

Aldeyra Therapeutics, Inc.

Data quality: 83%
ALDX
Nasdaq Manufacturing Chemicals
$1.58
▲ $0.01 (0.32%)
Mkt Cap: 94.79 M
Price
$1.58
Mkt Cap
94.79 M
Day Range
$1.52 — $1.63
52-Week Range
$1.07 — $6.18
Volume
2,056,783
Open $1.54
50D / 200D Avg
$4.20
62.54% below
50D / 200D Avg
$4.81
67.27% below

Quick Summary

Key Takeaways

Debt/Equity of 0.31 — conservative balance sheet
Negative free cash flow of -33.35 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-64.76%
Below sector avg (-51.02%)
ROIC-53.19%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
0.31
Below sector avg (0.33)
Current Ratio2.72
Interest Coverage-18.51

Valuation

PE (TTM)
-2.80
Below sector avg (-1.98)
P/B Ratio1.92
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -2.8 -2.0
P/B 1.9 5.1
ROE % -64.8 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E 0.3 0.3

ETFs Holding This Stock

IWV logo IWV iShares Russell 3000 ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -33.85 M
ROE -64.76% ROA -41.59%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -33.35 M
ROIC -53.19% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.31 Current Ratio 2.72
Interest Coverage -18.51 Asset Turnover N/A
Working Capital 48.98 M Tangible Book Value 49.24 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.80 Forward P/E N/A
P/B Ratio 1.92 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -35.18%
Market Cap 94.79 M Enterprise Value 50.75 M
Per Share
EPS (Diluted TTM) -0.56 Revenue / Share N/A
FCF / Share -0.55 OCF / Share -0.55
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 98.52%
SBC-Adj. FCF -41.57 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -33.85 M -55.85 M -37.54 M -62.02 M -57.78 M
EPS (Diluted) -0.56 -0.94 -0.64 -1.06 —
Gross Profit — — — — —
Operating Income -35.27 M -60.12 M -42.79 M -62.68 M -56.22 M
EBITDA — — — — —
R&D Expenses 25.66 M 48.22 M 29.46 M 47.31 M 44.94 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 1.91 M 1.93 M 2.07 M 1.69 M 1.74 M
Income Tax 0.0 1,000.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 72.06 M 104.61 M 148.33 M 181.29 M 233.14 M
Total Liabilities 27.81 M 33.60 M 28.53 M 30.28 M 27.40 M
Shareholders' Equity 44.25 M 71.00 M 119.80 M 151.01 M 205.74 M
Total Debt 15.30 M 15.30 M 15.29 M 16.34 M 16.04 M
Cash & Equivalents 70.04 M 54.53 M 144.42 M 144.42 M 229.79 M
Current Assets 71.78 M 104.07 M 147.81 M 181.02 M 232.75 M
Current Liabilities 27.81 M 18.60 M 22.26 M 15.36 M 11.77 M